• Clover Health Investments (NASDAQ:CLOV) is down 13% in after-hours trading Wednesday after releasing Q3 results that missed on the top line. The bottom line was a beat.
• The health insurer also boosted its full-year guidance midpoint to target an updated range of adjusted EBITDA profitability of $55M-$65M.
• In the quarter, the company's net loss narrowed to ~$9.2M compared to ~$41.5M in the year-ago period.
• Clover Health ended the quarter with restricted and unrestricted cash, cash equivalents, and investments of $531.4M, a 20.9% decline from the end of Q3 2023.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。